High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy ; volume:8 ; number:1 ; day:12 ; month:3 ; year:2018 ; pages:1-10 ; date:12.2018
Scientific reports ; 8, Heft 1 (12.3.2018), 1-10, 12.2018
- Creator
-
Lupini, Laura
- Contributor
-
Moretti, Anna
Bassi, Cristian
Schirone, Alessio
Pedriali, Massimo
Querzoli, Patrizia
Roncarati, Roberta
Frassoldati, Antonio
Negrini, Massimo
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-22312-x
- URN
-
urn:nbn:de:1111-201805125392
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lupini, Laura
- Moretti, Anna
- Bassi, Cristian
- Schirone, Alessio
- Pedriali, Massimo
- Querzoli, Patrizia
- Roncarati, Roberta
- Frassoldati, Antonio
- Negrini, Massimo
- SpringerLink (Online service)
Other Objects (12)
Cell-free circulating tumor DNA in cancer
Quantifying circulating cell-free DNA in humans
Circulating cell-free DNA use for diagnosing cholangiocarcinoma
Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
Elevated circulating high-sensitivity cardiac troponin t and cardiac remodeling in obesity
New approaches for detecting cancer with circulating cell-free DNA
Circulating cell-free DNA and its clinical utility in cancer
Clinical relevance of circulating cell-free microRNAs in ovarian cancer
Circadian rhythm and circulating cell-free DNA release on healthy subjects
Circulating cell-free DNA-based epigenetic assay can detect early breast cancer
Circulating cell-free DNA methylation mirrors alterations in cerebral patterns in epilepsy
Circulating cell-free DNA as a biomarker for diagnosis of Schistosomiasis japonica
Cell-free circulating tumor DNA in cancer
Quantifying circulating cell-free DNA in humans
Circulating cell-free DNA use for diagnosing cholangiocarcinoma
Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
Elevated circulating high-sensitivity cardiac troponin t and cardiac remodeling in obesity
New approaches for detecting cancer with circulating cell-free DNA
Circulating cell-free DNA and its clinical utility in cancer
Clinical relevance of circulating cell-free microRNAs in ovarian cancer
Circadian rhythm and circulating cell-free DNA release on healthy subjects
Circulating cell-free DNA-based epigenetic assay can detect early breast cancer
Circulating cell-free DNA methylation mirrors alterations in cerebral patterns in epilepsy
Circulating cell-free DNA as a biomarker for diagnosis of Schistosomiasis japonica
Cell-free circulating tumor DNA in cancer
Quantifying circulating cell-free DNA in humans
Circulating cell-free DNA use for diagnosing cholangiocarcinoma
Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
Elevated circulating high-sensitivity cardiac troponin t and cardiac remodeling in obesity
New approaches for detecting cancer with circulating cell-free DNA
Circulating cell-free DNA and its clinical utility in cancer
Clinical relevance of circulating cell-free microRNAs in ovarian cancer
Circadian rhythm and circulating cell-free DNA release on healthy subjects
Circulating cell-free DNA-based epigenetic assay can detect early breast cancer
Circulating cell-free DNA methylation mirrors alterations in cerebral patterns in epilepsy